Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: CellaVision Q3 EBITDA Grows To SEK 42 Million

Oct 22 (Reuters) - CellaVision AB  CEVI.ST :
    * STRONG SALES AND EARNINGS GROWTH IN LINE WITH IMPROVING
MARKET
CONDITIONS
    * Q3 EBITDA AMOUNTED TO SEK 42 MILLION (25)
    * Q3 NET SALES INCREASED BY 50% TO SEK 132 MILLION (88)
    * Q3 PROFIT BEFORE TAX AMOUNTED TO SEK 33 MILLION (16)
    * SUPPLY CHAIN DISTURBANCE WAS RESOLVED QUICKLY, AND
DELIVERY
CAPACITY REMAINED INTACT DURING QUARTER.
    * WE HAVE VALIDATED SECOND SOURCING OF CERTAIN KEY
COMPONENTS AND
WILL CONTINUE TO DO SO DEPENDENT ON SUPPLY CHAIN DEVELOPMENT
    * PREPARING TO ACCELERATE ACTIVITIES RELATED TO LOCAL MARKET
SUPPORT WITHIN SOME OF OUR EXISTING MARKETS
    * WE INTEND TO SEIZE GROWTH OPPORTUNITIES THROUGH
ACCELERATING OUR
EFFORTS IN DEVELOPING INDUSTRY-LEADING DCM SOLUTIONS

Source text for Eikon:  ID:nMFNQVTw9 
Further company coverage:  CEVI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on CellaVision AB

See all news